• 1
    Duchmann R, Zeitz M. Crohn's disease. In: OgraPL, MesteckyJ, LammME, StroberW, BienenstockJ, McGheeJR, eds. Mucosal immunology. San Diego: Academic Press, 2000: 105580.
  • 2
    Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003; 3: 321533.
  • 3
    Mathew CG, Lewis CM. Genetics of inflammatory bowel disease: progress and prospects. Hum Mol Genet 2004; 13: 1618.
  • 4
    Hampe J, Frenzel H, Mirza MM et al. Evidence for a NOD2-independent susceptibility locus for inflammatory bowel disease on chromosome 16p. Proc Natl Acad Sci USA 2002; 99: 3216.
  • 5
    Sanderson JD, Moss MT, Tizard ML, Hermon-Taylor J. Mycobacterium paratuberculosis DNA in Crohn's disease tissue. Gut 1992; 33: 8906.
  • 6
    Naser SA, Ghobrial G, Romero C, Valentine JF. Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease. Lancet 2004; 18: 103944.
  • 7
    Liu Y, Van Kruiningen HS, West AB, Cartun RW, Cortot A, Colombel JF. Immunocytochemical evidence of listeria, E. coli, and streptococcus antigens in Crohn's disease. Gastroenterology 1995; 108: 1369404.
  • 8
    Robertson D, Sandler R. Measles virus and Crohn's disease: a critical appraisal of the current literature. Inflamm Bowel Dis 2001; 7: 517.
  • 9
    Duchmann R, Kaiser I, Hermann E, Mayet W, Ewe K, Zum M. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol 1995; 102: 44855.
  • 10
    Ludwig D, Stahl M, Ibrahim ET et al. Enhanced intestinal expression of heat shock protein 70 in patients with inflammatory bowel disease. Dig Dis Sci 1999; 44: 14407.
  • 11
    Elsaghier A, Prantera C, Bothamley E, Wilkins E, Jindal S, Ivanyi J. Disease association of antibodies to human and mycobacterial hsp70 and hsp60 stress proteins. Clin Exp Immunol 1992; 89: 3059.
  • 12
    Pirzer U, Schonhaar A, Fleischer B, Hermann E, Meyer E, Meyersum Buschenfelde K-H. Reactivity infiltrating T lymphocytes with microbial antigens in Crohn's disease. Lancet 1991; 338: 12389.
  • 13
    Musch MW, Ciancio MJ, Sarge K, Chang EB. Induction of heat shock protein 70 protects intestinal epithelial IEC-18 cells from oxidant and thermal injury. Am J Physiol 1996; 270: C42936.
  • 14
    Wischmeyer PE, Musch MW, Madonna MB, Thisted R, Chang EB. Glutamine protects intestinal epithelial cells: role of inducible HSP70. Am J Physiol 1997; 272: G87984.
  • 15
    Lehner T, Bergmeier LA, Wang Y et al. Heat shock proteins generate β-chemokines which function as innate adjuvants enhancing adaptive immunity. Eur J Immunol 2000; 30: 594603.
  • 16
    Trinchieri G. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 1994; 84: 400627.
  • 17
    Parronchi P, Romagnani P, Annunziato F et al. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease. Am J Pathol 1997; 150: 82332.
  • 18
    Monteleone G, Biancone L, Marasco R et al. Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells. Gastroenterology 1997; 112: 116978.
  • 19
    Kakazu T, Hara J, Matsumo T et al. Type 1 helper cell predominance in granulomas of Crohn's disease. Am J Gastroenterol 1999; 8: 214955.
    Direct Link:
  • 20
    Fuss IJ, Neurath MF, Boirivant M et al. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-γ, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 1996; 157: 126170.
  • 21
    Breese EJ, Michie CA, Nicholls SW et al. Tumor necrosis factor α-producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology 1994; 106: 145566.
  • 22
    Reinecker H-C, Steffen M, Witthoeft T et al. Enhanced secretion of tumour necrosis factor-alpha, IL-6 and IL-1β by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 1993; 94: 17481.
  • 23
    Woywodt A, Neustock P, Kruse A et al. Cytokine expression in intestinal mucosal biopsies. In situ hybridisation of the mRNA for interleukin-1β, interleukin-6 and tumour necrosis factor-α in inflammatory bowel disease. Eur Cytokine Netw 1994; 5: 38795.
  • 24
    Kollias G, Douni E, Kassiotis G, Kontoyiannis D. On the role of tumor necrosis factor and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. Immunol Rev 1999; 169: 17594.
  • 25
    Targan SR, Hanauer SB, Van Deventer SJ et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med 1997; 337: 102935.
  • 26
    Rutgeerts P, Van Assche G, Vermeier S. Optimizing anti-TNF treatment in inflammatory bowel disease. Gastroenterology 2004; 126: 1593610.
  • 27
    Feldman M, Maini RN. Anti-TNF-α therapy of rheumatoid arthritis: what have we learned? Ann Rev Immunol 2001; 19: 16396.
  • 28
    Wang Y, Kelly CG, Karttunen JT et al. CD40 is a cellular receptor mediating mycobacterial heat shock protein 70 stimulation of CC-chemokines. Immunity 2001; 15: 97183.
  • 29
    Wang Y, Kelly CG, Singh M et al. Stimulation of Th1-polarizing cytokines, C-C chemokines, maturation of dendritic cells and adjuvant function by the peptide binding fragment of heat shock protein 70. J Immunol 2002; 169: 24229.
  • 30
    Wang Y, Whittall T, McGowan E et al. Identification of stimulating and inhibitory epitopes within the HSP70 molecule which modulate cytokine production and maturation of dendritic cells. J Immunol 2005; 174: 330616.
  • 31
    Mehlert A, Young DB. Biochemical and antigenic characterization of the Mycobacterial tuberculosis 71 kD antigen, a member of the 70 kD heat-shock protein family. Mol Microbiol 1989; 3: 12530.
  • 32
    Sallusto F, Lanzavecchia A. Mobilizing dendritic cells for tolerance, priming and chronic inflammation. J Exp Med 1999; 189: 611.
  • 33
    Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. In: PaulWE, FathmanCG, GlimcherLH, eds. Annual review of immunology, vol. 21. Palo Alto: Non-profit publishers, 2003: 685–711.
  • 34
    Moser M. Dendritic cells in immunity and tolerance − do they display opposite function [Review]. Immunity 2003; 19: 58.
  • 35
    Wright SD, Ramos RA, Tobias TS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990; 249: 14313.
  • 36
    Danese S, Sans M, Fiocchi C. The CD40/CD40L costimulatory pathway in inflammatory bowel disease. Gut 2004; 53: 103543.
  • 37
    Battaglia E, Biancone L, Resegotti A. Expression of CD40 and its ligand, CD40L, in intestinal lesions of Crohn's disease. Am J Gastroenterol 1999; 94: 327984.
    Direct Link:
  • 38
    Gelbmann CM, Leeb SN, Vogel D. Inducible CD40 expression mediates NFB activation and cytokine secretion in human colonic fibroblasts. Gut 2003; 52: 144856.
  • 39
    Vogel JD, West GA, Sturm A. CD40-mediated immune–nonimmune cell interactions induce mucosal fibroblast chemokines causing T-cell transmigration. Gastroenterology 2004; 126: 6380.
  • 40
    Liu Z, Colpaert S, D’Haens GR et al. Hyperexpression of CD40 ligand (CD154) in inflammatory bowel disease and its contribution to pathogenic cytokine production. J Immunol 1999; 163: 404957.
  • 41
    Sawada-Hase N, Kiyohara T, Miyagawa J et al. An increased number of CD40-high monocytes in patients with Crohn's disease. Am J Gastroenterol 2000; 95: 151623.
    Direct Link:
  • 42
    Clegg CH, Rulffes JT, Harald S et al. Thymus dysfunction and chronic inflammatory disease in gp39 transgenic mice. Int Immunol 1997; 9: 111122.
  • 43
    Becker T, Hartl F-U, Weiland F. CD40, an extracellular receptor for binding and uptake of Hsp70–peptide complexes. J Cell Biol 2002; 158: 127785.
  • 44
    Lazarevic V, Myers AJ, Scanga CA, Flynn JL. CD40, but not CD40L, is required for the optimal priming of T cells and control of aerosol M. tuberculosis infection. Immunity 2003; 19: 82335.
  • 45
    Millar DG, Garza KM, Odermatt B et al. HSP70 promotes antigen-presenting cell function and converts T-cell tolerance to autoimmunity in vivo. Nat Med 2003; 9: 1469523.
  • 46
    Hunt C, Morimoto RI. Conserved features of eukaryotic hsp70 genes revealed by comparison with the nucleotide sequence of human hsp70. Proc Natl Acad Sci USA 1985; 82: 64559.